Critics say stem cell panel skirting the law; Board didn't give proper notice of meeting, they say
By San Francisco Chronicle,
San Francisco Chronicle
| 12. 16. 2004
Even before its first meeting, the board being created to direct California's $3 billion stem cell program is stirring up controversy about whether it is complying with the state's open-government rules.
Terry Francke, general counsel of a Sacramento public interest group called Californians Aware, urged state Attorney General Bill Lockyer to delay the inaugural meeting of the stem cell board, scheduled for Friday in San Francisco.
In a letter to Lockyer, Francke gave his "strong endorsement" of a protest filed by Charles Halpern, an independent public interest lawyer in Berkeley who is alleging the official agenda and public notice for the Friday meeting fail to comply with the state Bagley-Keene Act, which mandates open meetings of public agencies.
Halpern previously had tried to win a seat on the board, known as the Independent Citizens Oversight Committee. Although that didn't happen, Halpern said he still intends to make his views known as the stem-cell enterprise gets under way.
Halpern asserted that planners of the Friday meeting did not provide enough advance notice, gave only cursory descriptions of agenda items, provided no...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...